Immortalized Human Retinal Endothelial Cells-SV40T

Cat.No.: CSC-I2036Z

Species: homo sapiens

Morphology: Polygonal

Culture Properties: Adherent

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-I2036Z
Description
Immortalized Human Retinal Endothelial Cells-SV40T provided by Creative Bioarray were developed by immortalizing primary human retinal endothelial cells with SV40T. The cells are characterized by unlimited growth (at least 30 passages) while maintaining expression of cell type specific markers and functions.
Species
homo sapiens
Recommended Medium
SuperCult® Immortalized Human Retinal Endothelial Cell Medium (Cat No.: CM-I2036Z)
Freezing Medium
Complete medium supplemented with 10% (v/v) DMSO
Culture Properties
Adherent
Morphology
Polygonal
Immortalization Method
SV40 large T antigen
Application
For Research Use Only
Growth Properties
Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2.
Shipping
Dry Ice.
Quality Control
Real Time PCR was used to quantify SV40T gene expression in immortalized cell line. Free from contaminations (bacteria incl. mycoplasma, fungi, HIV, HAV, HBV, HCV, Parvo-B19) and cross-contaminations.
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.

Note: Never can cells be kept at -20°C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Immortalized Human Retinal Endothelial Cell line (iHRECs-SV40T) was developed from primary human retinal endothelial cells isolated and then immortalized by Simian Virus 40 Large T antigen (SV40T) insertion. The cell line has been used as an ophthalmic research model for BRB properties and vasodegenerative disorders.

Phenotypically, iHRECs-SV40T maintain crucial characteristics similar to primary cells. They express endothelial markers CD31 (PECAM-1), von Willebrand Factor (vWF), tight junction proteins ZO-1 and Occludin, which are responsible for the restrictive permeability characterizing the inner blood-retinal barrier. As they also show strong angiogenic properties in vitro, such as the capacity for tube formation, they are a widely used model for pathological angiogenesis, making them suitable for the study of diseases such as Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD) and Retinopathy of Prematurity (ROP). The cell line can be used to study the molecular mechanism of pathological neovascularization, inflammatory cytokine responses and oxidative stress in retinal microenvironment. They are also a useful research tool to better understand BRB physiology, while also providing a scalable platform for the evaluation of novel anti-angiogenic agents and delivery vehicles targeting the posterior segment of the eye in a model that is closer to human physiology than animal models.

Overexpression of miR-128-3p Alleviates HG-induced DR Inflammatory Injury

Diabetic retinopathy (DR) is closely related to inflammatory injury. In this study, Wen et al. first established a DR cellular model by treating immortalized human retinal endothelial cells (IM-HRECs) with high-glucose (HG). They used the CCK-8 assay to detect cell viability, ELISA to measure the inflammatory cytokines (TNF-α, IL-1β, and IL-10), and RT-qPCR to detect the expression of miR-128-3p.

HG treatment significantly decreased cell viability and IL-10 expression (Fig. 1A, B) and markedly increased TNF-α and IL-1β levels (Fig. 1B) compared with the control group. This indicated that HG treatment induced DR inflammatory injury. RT-qPCR results also revealed that miR-128-3p expression was lower in the HG group than in the control group (Fig. 1C). This suggested that miR-128-3p might be a potential therapeutic target for DR. In order to verify the regulatory role of miR-128-3p in DR inflammatory injury, they increased miR-128-3p in IM-HRECs (Fig. 1C, D). Overexpression of miR-128-3p significantly improved the viability and IL-10 expression (Fig. 1A, B) and decreased TNF-α and IL-1β levels (Fig. 1B) in HG-treated cells. This indicated that overexpression of miR-128-3p could relieve HG-induced DR inflammatory injury.

Overexpression of miR-128-3p alleviates HG-induced DR inflammatory injury.

Fig. 1. Overexpression of miR-128-3p alleviates HG-induced DR inflammatory injury (Wen W M, Feng J B, et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products